COMP <GO>
IRON vs JNJ // ENTERPRISE SCALE & MARKET CAP
Disc Medicine Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: IRON 5
— JNJ 8
▲ ENTERPRISE SCALE & MARKET CAP LEADER: JNJ
LAST: $80.84 (-2.41%) • MKT CAP: $3.68B
market-cap
$3.68B
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
market-cap
$662.49B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IRON VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IRON | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 67.90% | -26.90 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -27.50% | 25.50% | -53.00 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -4.93% | 2.97% | -7.90 | JNJ | /fcf-yield <GO> |
| Operating Margin | -22.90% | 34.70% | -57.60 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -20.60% | 28.50% | -49.10 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 16.50% | 6.00% | +10.50 | IRON | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 5.59 | +20.41 | IRON | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 7.20% | -0.60 | IRON | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.8 | 60.4 | +4.45 | IRON | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 1.08 | -0.18 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.0x | 23.0x | -3.00 | IRON | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $3.68B | $662.49B | -$658.81B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IRON REV | JNJ REV | IRON GROSS % | JNJ GROSS % | IRON FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $94.19B | — | 67.9% | -$181.3M | $19.70B |
| FY 2024 | $0 | $88.82B | — | 69.1% | -$94.4M | $19.84B |
| FY 2023 | $0 | $85.16B | — | 44.0% | -$73.5M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IRON // BETA 0.90
JNJ // BETA 1.08